Real-time enrollment status for this primary myelofibrosis clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 10:00 PM UTC
| NCT Number | NCT06343805 |
| Recruiting Status | Recruiting |
| Condition | Primary Myelofibrosis |
| Phase | PHASE1 |
| Target Enrollment | 256 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Ajax Therapeutics, Inc. |
| Last Updated on CT.gov | October 9, 2026 (3 days ago) |
As of October 12, 2026: Clinical trial NCT06343805 is currently recruiting participants. This phase1 study for primary myelofibrosis is actively seeking new participants at 13 locations across the United States. The study is sponsored by Ajax Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06343805 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06343805 was last updated 3 days ago (October 9, 2026). HelloStudys verifies this status automatically.